1

Supplemental Materials Supplemental Methods
Recruitment and sequencing
Genetic variants were identified from whole genome sequencing (WGS) data using Isaac (Illumina Inc.) or as described previously for whole exome sequencing.
1 Clinical and laboratory phenotypes were recorded in raw form and as Human Phenotype Ontology (HPO) terms along with pedigree data. 1 The propositus' genetic and phenotypic data were analyzed as part of a dataset of from 9,472 study participants that have undergone genetic analysis, which includes 1,472 cases with unexplained BPDs.
Platelet imaging
Platelet imaging was performed using a structured illumination microscope (SIM, Elyra S.1, Zeiss, Heidelberg, DE). Images were analyzed with ZEN Black (Carl Zeiss Inc., Oberkochen, DE) and ImageJ software (National Institutes of Health (NIH), Bethesda, MD). 2 Raw 3D SIM images were processed to super-resolution SIM using ZEN Black software, followed by maximum intensity projection as previously described. 3 
Metabolic profiling
In the targeted sphingolipid profiling protocol, for the identification of KDS we used a Thermo Scientific QExactive Orbitrap (ThermoFisher Scientific, Hemel Hempstead, UK) set up to fragment the 300.3 ion (±2 m/z) using a relative collision energy of 30. The KDS standard used was purchased from Matreya LLC (Cat. no.
1876, State College, PA). All samples were snap frozen in dry ice and stored at -80 C until analysed. Zebrafish lysates for sphingolipid profiling were prepared as for immunoblot analysis, using 20 embryos per condition, in triplicate, isolated at 72 hours post fertilisation [hpf] . 4 Stem cell differentiation assays CD34 + hematopoietic stem cells (HSC) isolated from bone marrow aspirates from the propositus (at 5 years of age) and an unrelated control, and from peripheral blood from the propositus (at 8•5 years of age), his affected sister (at 5 months of age) and an unrelated control were stored in liquid nitrogen. The recovered (differentiation day 0) CD34+ HSCs were cultured in StemSpan SFEM medium with StemSpan CC100 ensuring strong expansion of HSC for 3 days (Stem Cell Technologies, Vancouver, CA).
The expanded bone marrow derived HSC were used to perform colony assays for MK (CFU-MK) and granulocytes, erythrocytes, monocytes, and MK (GEMM; CFU-GEMM) as described previously. 4, 5 These were performed in quintuple for MegaCult-C 04973 (MK) and triplicate for MethoCult 04964 (GEMM, StemCell
Technologies, Vancouver, CA). MK (after Giemsa staining) and GEMM (without staining) colonies were counted by two independent operators using a Zeiss Axiovert 200M microscope (Carl Zeiss Inc.) or light microscope (Leica DM RBE, Wetzlar, DE), respectively. Colonies from GEMM plates were further analysed by flow cytometry using FITC-labelled mouse antibodies against glycophorin A (CD235a; BD Biosciences, San
Jose, CA) and PE-labelled mouse antibodies against CD45 (Clone T29/33; Dako, Glostrup, DK).
Liquid MK cultures were derived from bone marrow-and peripheral blood-derived HSC at day 3 of differentiation by incubation with 50ng/ml thrombopoietin (TPO), 25ng/ml stem cell factor, and 10ng/ml interleukin 1β (Peprotech, Rocky Hill, NJ,). MK were analysed by flow cytometry on total differentiation day 7
with FITC-labelled antibodies against CD41 and CD42 (BD Biosciences) and on total differentiation day 11 for proplatelet formation and immunostaining of cytoskeletal proteins F-actin, phalloidin-rhodamine (Sigma, St Louis, MO), and anti-tubulin (ThermoFisher Scientific), and δ-granule and lysosome marker CD63 (Santa Cruz, Dallas, TX). 5, 6 For immunostaining MK were seeded for 4 hours on fibrinogen-coated coverslips and stained cells were photographed at 63x magnification with a confocal microscope (AxioObserver.Z1, Zeiss, Heidelberg, DE). MK cell size was determined by F-actin staining and images were analyzed with ImageJ software (NIH 2 ).
Three random control images were used to optimize parameters and MK were excluded if the ploidy was unclear following F-actin staining, as described. approximately one month after reprogramming, clones were picked, passaged to feeder-free conditions, and validated. iPSC were cultured feeder-and antibiotic-free in Essential 8 medium (ThermoFisher Scientific).
Lentiviral particle production, transduction and selection
Replication-deficient lentiviral vector particles were produced by transient co-transfection of HEK 293T cells with the rescue or empty vector and a 2 nd generation packaging system consisting of psPAX2 and pCMV-VSV-G (Addgene #12260, #8454). Viral particles were concentrated by the LentiX-concentrator system (Clontech).
Transduction was performed in iPSC at MOI 2, in the presence of protamine sulphate 10μg/ml (Sigma) and was followed by plate centrifugation at 2500 rpm for 45 minutes at 37 C. Cells carrying the rescue or empty vector were selected after 72 hours using 0•1μg/ml puromycin (Sigma).
Forward programming to MK (iMK)
Passage to single iPSC was obtained using TrypLE (ThermoFisher Scientific) followed by culture in Essential 8 media containing 10µM ROCK inhibitor (Sigma) for 24 hours prior to lentiviral transduction with FLI1, GATA1, and TAL1 using a protocol for generating MK described by Moreau et al. 10 The MK obtained by this protocol (named iMK hereafter) were defined at day 20 post-transduction by absence of staining with 1μg/ml DAPI (Sigma; at this concentration live iMK are impermeant to DAPI) and dual staining with anti-CD41a-APC and anti-CD42b-PE (1:100, cat. 559777 and 1:1000, cat. 555473, respectively, BD Biosciences) on the Beckman Coulter Gallios Cytometer. Cytometry results were analysed using Kaluza Analysis v.1.5a (Beckman Coulter).
Proplatelet assay
iMK were placed at a concentration of 0•5x10 6 /ml in CellGro medium (CellGenix) for seeding on sterile glass coverslips coated with 200µg/ml fibrinogen (Sigma) in phosphate-buffered saline (PBS). Cells were fixed in 1% paraformaldehyde at 4 hours or 24 hours after seeding. Cells were quenched with 50µM ammonium chloride and permeabilized with 0•1% saponin, 0•2% gelatin, and 0•02% azide (Sigma) in PBS. Staining was performed with antibody against α-tubulin (1:250, cat.T5168, Sigma), 1μg/ml DAPI (Sigma), and goat anti-mouse Alexa Fluor 488 antibody (1:1000, cat. A21121, ThermoFisher Scientific). Cells were examined within 48 hours using a Leica DMi8 fluorescent microscope and images were analysed using FIJI software. 2 Five to ten representative fields were examined to ensure at least 100 iMK were observed for each experimental condition. Proplatelets were defined as clear projections from the main cell body with approximately parallel sides to the shaft. Results were compared using the paired, two-tailed Student's t-test.
RNA sequencing 1 x 10 5 iMK were stored in 500 µl Trizol reagent (ThermoFisher Scientific) at -80 C. RNA was recovered for sequencing (RNA-seq) with the Direct-zol RNA MiniPrep kit (Zymo). RNA was quantified using the Qubit RNA HS Assay kit (ThermoFisher Scientific) and its quality was confirmed using the Agilent RNA 6000 Pico kit on the Agilent 2100 Bioanalyzer. cDNA libraries were prepared using the KAPA Stranded RNA-Seq Kit with Riboerase (Roche) and Agencourt AMPure XP beads (Beckman Coulter) for purification. Libraries were quantified by RT-qPCR with the KAPA Library Quantification Kit (Roche). Libraries were sequenced at the Cancer Research UK Cambridge Institute Genomics Core) on a HiSeq4000 (Illumina Inc.) using 150bp read length paired-end sequencing. Sequences were aligned with STAR 11 and read counts were obtained using featureCounts 12 with respect to Ensembl v.70 of reference genome build GRCh37. Expression of transcripts and genes was quantified using MMSEQ and differential expression was assessed using MMDIFF 13, 14 . The prior probability of differential expression was set to 0•1 and a posterior probability >0•5 was used to declare a transcript being differentially expressed. (C) Platelet light transmission aggregometry studies.
The propositus had normal aggregation responses for ristocetin (105%), arachidonic acid (95%), U46619 (111%), collagen at 2 μg/ml (70%) and ADP at 5 μM (97%). Only the response to low dose of collagen was mildly reduced. Amplitude for ADP 2.5 μM 52% 48 and 28% *All aggregations were performed using platelet-rich plasma at 90x10 3 platelets/μL.
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Supplemental Table 2 Ion counts from Metabolon analysis of plasma sphingolipids from the propositus, healthy brother, parents, and 496 unrelated controls. 
3-ketosphinganine (KDS) was
Supplemental Figure 4 Heatmap of KDSR transcripts in MK and platelets (Plt)
Transcripts present at >0•5 log FPKM (fragments per kilobase of transcript per million mapped reads) are shown and schematically represented. Key structural elements and variant annotation are as defined in Figure 1 . The variants present in the affected siblings are highlighted in bold, and are present in the major transcripts present in MK (ENST00000406396, ENST00000591902) but not platelets (ENST00000592327, ENST00000590056, http://blueprint.haem.cam.ac.uk). 8 This is in keeping with previous reports that de novo sphingolipid synthesis plays a minimal role in mature platelets. 
Supplemental Figure 6
Zebrafish experiments Tg(cd41:EGF) embryos were injected with a kdsr ATG-MO (1000 µM) or with buffer (control). At 72 hpf most embryos developed curled tails but no other dysmorphisms. Liquid megakaryocyte cultures show impaired proplatelet formation (A) MK proplatelet formation was measured at day 11 of differentiation using bone marrow-derived CD34+ HSC from the propositus and controls. Propositus-derived MK were unusually large and displayed reduced proplatelet formation. (B) MK proplatelet formation was measured at day 12 of differentiation using peripheral blood derived CD34+ HSC from the propositus and affected sister. Again, MK from the patients were large and displayed membrane budding (arrows) but did not form normal proplatelets. Scale bars indicate 50 μm.
Supplemental Figure 10
Immunostaining of CD34+ stem cell-derived megakaryocytes confirm impaired proplatelet formation, and show abnormal cytoskeletal organisation Megakaryocytes derived from bone marrow (BM) or peripheral blood (PB) were spread on fibrinogen and immunostained with antibodies against cytoskeletal marker F-actin (red) and δ-granule marker CD63 (green). MK for the propositus and his affected sibling showed irregular cytoskeletal structures that resembled filopodia (*). Proplatelet formation was infrequent and observed proplatelets demonstrated reduced δ-granule trafficking (arrow). Scale bars indicate 20μm. 
